Could a cancer drug help control HIV?
NCT ID NCT05187429
Summary
This study is testing if a single, low dose of the immunotherapy drug nivolumab can help reduce the hidden, inactive 'reservoir' of HIV in the body. It involves 42 adults living with HIV who are on stable antiretroviral therapy. The goal is to see if this approach can help the immune system better control the virus, potentially moving toward a future where less medication is needed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Hospital - Department of Infecious Diseases
RECRUITINGMelbourne, Victoria, 3181, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tan Tock Seng Hospital
RECRUITINGSingapore, 308433, Singapore
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.